Outcomes of Treatment With Spesolimab in Patients With Moderate to Severe Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial
Br J Dermatol 2024 Apr 05;[EPub Ahead of Print], A Alavi, E Prens, AB Kimball, JW Frew, JG Krueger, S Mukhopadhyay, H Gao, U Ranganathan, NB Ivanoff, AC Hernandez Daly, CC ZouboulisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.